Navigation Links
Sundia Receives 2011 Zero2IPO Venture 50 Award
Date:11/21/2011

SHANGHAI, Nov. 21, 2011 /PRNewswire-Asia/ -- Sundia MediTech Company Inc., a leading pharmaceutical Contract Research Organization (CRO) in China, announced that the company was named one of the 50 best companies for investment in China in 2011 by Zero2IPO. The news was announced at an October ceremony in Shanghai. This is the third time for Sundia to get this prestigious award after it was previously named in 2007 and 2008.

Zero2IPO-Venture 50 was launched by Zero2IPO Group in 2006. Until now it has become the highest level of enterprise appraisal by venture capitalists in China, and reflects the enterprise with the most potential. The 50 enterprises with the most investment value were selected from a pool of thousands of nominated companies in leading industries by evaluating nominees' business on management team, ownership structure, business model, competitiveness, industry and market, financial situation and forecast, management risks and strategy.

Sundia was founded in 2004 in Shanghai by a group of biotech and pharmaceutical industry veterans from North America. The company has provided integrated R&D outsourcing services to biotech and pharmaceutical clients worldwide. Over the past 7 years, Sundia has successfully established collaborations with over 100 clients in North America, Europe, Japan, Korea and China. Now, Sundia has become a top CRO company in China with 700 employees with operations in Shanghai and Shijiazhuang, the capital city of Hebei Province in Northern China.

Dr. Xiaochuan Wang, Chairman of Sundia attended the ceremony and made a reception speech. "We really appreciate the venture investor for voting Sundia into Venture 50 again. It is recognition of the effort of all of our team members," she acknowledged.


'/>"/>
SOURCE Sundia MediTech Company Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
2. Vascular Designs, Inc. Receives CE Mark Approval for Its IsoFlow™ Infusion Catheter to Target Cancerous Tumors
3. Qualitest Pharmaceuticals Receives FDA Approval for Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL
4. First Patient Receives FDA-Approved Telescope Implant for End-Stage Macular Degeneration
5. Ethicon Endo-Surgery Receives 510(k) Clearance for New ENSEAL® G2 Curved and Straight Tissue Sealers Line -- Broadest Range of Advanced Bipolar Tissue Sealers Available for Open and Minimally Invasive Surgery
6. Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System
7. IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System
8. Augurix Diagnostics Receives the 2011 Debiopharm /Valais Award for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease
9. The Childrens Hospital of Philadelphia Receives Grand Challenges Explorations Funding
10. Femasys Receives FDA 510(k) Clearance for First Low Pressure HSG Device
11. PTC Therapeutics Receives Grand Challenges Explorations Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Research and Markets has announced the addition of ... offering. ... This report analyzes the worldwide markets for Endodontic Supplies in US$ Thousand. ... , Japan , Europe , ... Annual estimates and forecasts are provided for the period 2015 through ...
(Date:12/8/2016)... 8, 2016   TriNetX , the health ... Hospital signed a membership agreement to join ... of new cures. The TriNetX network ... million patients globally, biopharmaceutical companies and contract research ... protocol design, site selection, patient recruitment, and collaborative ...
(Date:12/8/2016)... LAVAL, Quebec , Dec. 8, 2016 /PRNewswire/ ... and TSX: VRX) ("Valeant") today announced positive ... vehicle-controlled clinical study to assess the safety and ... in the treatment of plaque psoriasis. ... adult subjects with moderate to severe psoriasis, IDP-118 ...
Breaking Medicine Technology:
(Date:12/10/2016)... (PRWEB) , ... December 10, 2016 , ... When faced ... worried about germs spreading from the seat to her body, and contamination of children ... and effective way to solve this problem that many people face. , The patent-pending ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... planning assistance from offices in Pasco and Richland, is initiating a charity drive ... serious injuries resulting from a recent automobile collision. , On October 29th ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... pharmaceutical inserts and outserts. As a means of expanding capabilities Flottman has ... enable Flottman to individually code professional inserts (PIs) and patient package inserts (PPIs) ...
(Date:12/9/2016)... ... 09, 2016 , ... The Justin Veatch Fund announced Thursday that ... the film Whispering Spirits and its discussion guide for use by all ... tool in the war against teen drug abuse. NCADD is the oldest anti-addiction ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted ... all types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves ... use and could be set up in a matter of minutes, or even seconds. ...
Breaking Medicine News(10 mins):